Month: September 2026

Cipla and Qilu Pharmaceutical Forge US Licensing Pact for QL2107, a Pembrolizumab Biosimilar Targeting Blockbuster Keytruda® Pharm up 7
2 min read

Cipla and Qilu Pharmaceutical Forge US Licensing Pact for QL2107, a Pembrolizumab Biosimilar Targeting Blockbuster Keytruda®

Pharm'Up
Invagen Pharmaceuticals Inc., a wholly owned subsidiary of Indian multinational pharmaceutical company Cipla Limited (BSE: 500087; NSE:...
Read More Read more about Cipla and Qilu Pharmaceutical Forge US Licensing Pact for QL2107, a Pembrolizumab Biosimilar Targeting Blockbuster Keytruda®
Saveetha College of Pharmacy and IPGA Host National Virtual Faculty Development Programme to Align Pharmaceutical Academics with NEP 2020 Pharm up 6
2 min read

Saveetha College of Pharmacy and IPGA Host National Virtual Faculty Development Programme to Align Pharmaceutical Academics with NEP 2020

Pharm'Up
Saveetha College of Pharmacy, a constituent unit of the Saveetha Institute of Medical and Technical Sciences (SIMATS),...
Read More Read more about Saveetha College of Pharmacy and IPGA Host National Virtual Faculty Development Programme to Align Pharmaceutical Academics with NEP 2020
Alkem Laboratories Launches Renocia Exo™: India’s First Patented Ginsenoside Phyto-Exosome Serum for Comprehensive Hair Loss Management Pharm up 5
2 min read

Alkem Laboratories Launches Renocia Exo™: India’s First Patented Ginsenoside Phyto-Exosome Serum for Comprehensive Hair Loss Management

Pharm'Up
Mumbai-based pharmaceutical leader Alkem Laboratories Ltd. has expanded its presence in regenerative dermatology with the national launch...
Read More Read more about Alkem Laboratories Launches Renocia Exo™: India’s First Patented Ginsenoside Phyto-Exosome Serum for Comprehensive Hair Loss Management
McMaster University Unveils Hidden Molecular Switch in PF4 That Triggers Fatal Blood Clots During Heparin Therapy Pharm up 4
2 min read

McMaster University Unveils Hidden Molecular Switch in PF4 That Triggers Fatal Blood Clots During Heparin Therapy

Pharm'Up
Biochemical researchers at McMaster University have uncovered a fundamental molecular mechanism explaining why heparin—one of the world’s...
Read More Read more about McMaster University Unveils Hidden Molecular Switch in PF4 That Triggers Fatal Blood Clots During Heparin Therapy
Novel Inherited Retinal Disorder Linked to EFEMP1 Mutation Shows Functional Night-Vision Deficits Years Ahead of Structural Tissue Damage Pharm up 3
2 min read

Novel Inherited Retinal Disorder Linked to EFEMP1 Mutation Shows Functional Night-Vision Deficits Years Ahead of Structural Tissue Damage

Pharm'Up
An international consortium of vision researchers has characterized a previously undocumented inherited retinal disease triggered by a...
Read More Read more about Novel Inherited Retinal Disorder Linked to EFEMP1 Mutation Shows Functional Night-Vision Deficits Years Ahead of Structural Tissue Damage

Read These Too

Pharm up 7
2 min read

Cipla and Qilu Pharmaceutical Forge US Licensing Pact for QL2107, a Pembrolizumab Biosimilar Targeting Blockbuster Keytruda®

Pharm'Up
Pharm up 6
2 min read

Saveetha College of Pharmacy and IPGA Host National Virtual Faculty Development Programme to Align Pharmaceutical Academics with NEP 2020

Pharm'Up
Pharm up 5
2 min read

Alkem Laboratories Launches Renocia Exo™: India’s First Patented Ginsenoside Phyto-Exosome Serum for Comprehensive Hair Loss Management

Pharm'Up
Pharm up 4
2 min read

McMaster University Unveils Hidden Molecular Switch in PF4 That Triggers Fatal Blood Clots During Heparin Therapy

Pharm'Up